Prenatal closure of the ductus arteriosus (DA) is associated with maternal ingestion of cyclooxygenase inhibitors during pregnancy. We report a case of prenatal DA closure after maternal ingestion of MonaVie, a juice blend containing the cyclooxygenase and nitric oxide synthase inhibitors anthocyanins and proanthocyanidins. A G 2 P 0 Ab 1 woman had an uncomplicated first and second trimester and normal 20-week fetal ultrasound. At 37 weeks, she developed polyhydramnios; a fetal echocardiogram showed right atrial and ventricular (RV) enlargement with RV dysfunction. Immediately after birth, there was pulmonary hypertension by echocardiogram with DA closure, severe RV hypertrophy and dysfunction, and marked right-to-left atrial shunting. Improvement occurred over 3 weeks with the neonate tolerating room air and a follow-up echocardiogram showing minimal atrial shunting and improved RV function. This report shows an association between MonaVie ingestion throughout pregnancy and prenatal DA closure resulting in cardiac dysfunction and pulmonary hypertension at birth.
Introduction
Prenatal closure of the ductus arteriosus (DA) is associated with maternal ingestion of prostaglandin synthesis inhibitors during pregnancy. [1] [2] [3] After DA closure, pulmonary artery blood flow increases resulting in excessive right heart workload. This may result in pulmonary artery remodeling with medial hypertrophy, right ventricular (RV) dysfunction and pulmonary artery hypertension (PAH) at birth, 4, 5 which carry significant morbidity and mortality. 2, 4 Although local prostanoid synthesis contributes to DA patency in late gestation, local nitric oxide (NO) contributes in early pregnancy. 6 Thus, there is a transition between the two modalities of ductal vasodilation during fetal development. We report a case of prenatal DA closure in a woman who ingested a juice blend containing high concentrations of anthocyanins and proanthocyanidins 7 throughout pregnancy, which are inhibitors of prostaglandin and NO synthesis.
7-10
Case A 28-year-old Caucasian female (G 2 P 0 Ab 1 ) was seen at 5 weeks of gestation. The medical history was unremarkable, and only prenatal vitamins were prescribed. The first and second trimesters were uncomplicated. A 20-week fetal sonogram revealed a normal four-chambered heart and outflow tracts. An ultrasound at 28 weeks revealed normal placentation, amniotic fluid volume and fetal heart (Figure 1a ). At 37 weeks the fundal height increased to 38 cm; a repeat fetal sonogram revealed a weight of 3864 gm (>90%), polyhydramnios and a 41-cm amniotic fluid index. The heart showed right atrial (RA) enlargement, a patent foramen ovale (PFO), RV dilation with hypertrophy, severe RV dysfunction, and a small left ventricular outflow tract and aortic valve. At the Children's Medical Center, Dallas, TX, USA, a detailed echocardiogram showed marked RA dilation, right-to-left shunting through the PFO, and severe RV dilation, hypertrophy and dysfunction (Figure 1b) . There was concern for prenatal DA closure or aortic coarctation with inadequate DA flow. The aortic arch was inadequately imaged and the ductal arch was not identified. The patient underwent an elective primary cesarean delivery the following day at the Parkland Memorial Hospital, Dallas, TX, USA. The neonate weighed 3809 gm. Apgar scores were 8 and 8 at 1 and 5 min, respectively. At 6 min, the neonate was cyanotic and the oxygen saturation was B30% in 100% O 2 . He was intubated, transferred to the neonatal intensive-care unit, and placed on mechanical ventilation and intravenous prostaglandin E 2 (PGE 2 ). An echocardiogram at <1 h showed a large dilated RA, a severely dilated and hypertrophied RV with depressed systolic function, normal left ventricular function ( Figure 2a ) and DA closure ( Figure 2b ) with right-to-left shunting across the PFO. The aortic arch was unobstructed. The RV-RA systolic gradient was 55 mm Hg, and mean systemic pressure was 38 mm Hg. These findings suggested severe RV dysfunction, an elevated pulmonary vascular resistance and PAH; blood gases were P a O 2 72 mm Hg in 96% O 2 , P a CO 2 41 mm Hg and pH 7.42. The oxygen index was 15.8. PGE 2 was discontinued; the P a O 2 and pH a were maintained at X100 mm Hg and X7.30, respectively, in the absence of inhaled NO. The neonate was weaned from oxygen and extubated on day 5. At that time an echocardiogram showed a persistent PFO with bidirectional shunting, RV and RA enlargement, and persistent, but improved RV dysfunction and hypertrophy. The RV-RA systolic gradient was 31 mm Hg. The neonate was discharged at day 25 with normal oxygen saturations in room air, tolerating feeds and growing adequately. The echocardiogram showed mild RA dilatation, absent right-to-left PFO shunting and improved RV hypertrophy.
Although the mother denied medications except prenatal vitamins, including potential cyclooxygenase inhibitors, she subsequently revealed ingesting 2 to 4 ounces per day of MonaVie beginning in the first trimester, believing it would promote well-being during the pregnancy. There were no contraindications noted and no information about potential for deleterious fetal effects, if taken during pregnancy.
Discussion
Prenatal DA patency is regulated by a balance between vasodilating and vasoconstricting factors. 11 Near term, the DA exhibits a relatively high level of intrinsic tone partially because of increasing Prenatal closure of the ductus arteriosus V Kapadia et al O 2 sensitivity normally offset by DA synthesis of NO and prostaglandins. 11, 12 Although additional factors may promote DA tone, for example, smooth muscle maturation, they remain poorly understood. In contrast, the DA vasodilating mechanisms are better understood. In early gestation, NO synthesis has a prominent role. 11 Subsequently, PGE 2 , derived from DA cyclooxygenase 1 and/or 2, is the predominant agent opposing ductal constriction. 13 Furthermore, the fetal DA is exposed to high circulating levels of placental PGE 2 , reflecting the reduced pulmonary clearance secondary to low pulmonary blood flow. 11 Inhibition of these prostaglandins by exposure to non-steroidal anti-inflammatory drugs may cause DA closure. 2, 14 When the DA closes prenatally, blood flow increases through the high-resistance pulmonary vascular bed. This increases RV afterload and causes RV dilation and hypertrophy, and subsequently, RV dysfunction and failure with increased RA pressure and right-to-left shunting across the PFO. This is paralleled by pulmonary artery remodeling and a risk for PAH at birth. 5 Notably, this is a model for studying PAH. 4, 5 When heart failure occurs, fetal swallowing decreases and polyhydramnios develops, 14 which lead to the diagnosis of heart disease in our case and a planned delivery. Fortunately, the PAH was not intractable, and the neonate responded to moderate ventilatory support and oxygen supplementation.
The mother denied taking cyclooxygenase inhibitors, but subsequently revealed daily ingestion of the juice blend MonaVie beginning in the first trimester. MonaVie is a blend of the Brazilian ac¸ai berries plus 18 other fruits and only sold online. It is said to have anti-inflammatory properties that improve health, 10 and its use in pregnancy is unknown. It contains high concentrations of proanthocyanidins and anthocyanins (Table 1) , 9 polyphenols belonging to a group of water-soluble phytochemicals exhibiting antioxidative and anti-inflammatory properties, 7-9 which inhibit cyclooxygenase 2 7-9 and variably alter NO synthesis. 9, 15 If transplacental transport occurs, they may inhibit or attenuate fetal prostanoid and NO synthesis. However, their transplacental transport and metabolism in pregnancy are unknown. We propose that placental transport of proanthocyanidins and anthocyanins in MonaVie caused prolonged fetal cyclooxygenase and NO synthase inhibition. We recommend pregnant women not to ingest dietary supplements containing proanthocyanidins and anthocyanins until their metabolism and placental transport have been examined. Prenatal closure of the ductus arteriosus V Kapadia et al
